Erratum: Timing of early invasive intervention in patients with moderate to high risk acute coronary syndromes (Journal of Interventional Cardiology (2012) 25 (10-18) DOI: 10.1111/j.1540-8183.2011.00685.x);Timing of early invasive intervention in patients with moderate to high risk acute coronary syndromes

Journal of Interventional Cardiology

Volumn 25, Issue 1, 2012, Pages 10-18

  Jiang, Meng ^a   He, Ben ^a   Zhang, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ARTERY CATHETERIZATION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DEATH; EARLY INTERVENTION; EARLY INVASIVE INTERVENTION; HEART INFARCTION; HIGH RISK PATIENT; INFORMATION RETRIEVAL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION;

EID: 84857656381     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00741.x     Document Type: Erratum

References (27)

1. Boden WE, O'Rourke RA, Crawford MH, et al,. Outcomes in patients with acute non-q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-q-wave Infarction Strategies in Hospital (vanqwish) trial investigators. N Engl J Med 1998; 338: 1785-1792. (Pubitemid 28277958)
2. Anderson HV, Cannon CP, Stone PH, et al,. One-year results of the thrombolysis in myocardial infarction (TIMI) IIIb clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-q wave myocardial infarction. J Am Coll Cardiol 1995; 26: 1643-1650.
3. de Winter RJ, Windhausen F, Cornel JH, et al,. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005; 353: 1095-1104. (Pubitemid 41317432)
4. Anderson JL, Adams CD, Antman EM, et al,. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50: e1-e157.
5. Bassand JP, Hamm CW, Ardissino D, et al,. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-1660.
6. Liberati A, Altman DG, Tetzlaff J, et al,. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009; 339: b2700.
7. Higgins JP, Thompson SG, Deeks JJ, et al,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. (Pubitemid 37088507)
8. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. (Pubitemid 30214957)
9. Tricoci P, Peterson ED, Chen AY, et al,. Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from crusade). Am J Cardiol 2007; 99: 1389-1393. (Pubitemid 46686637)
10. McCullough PA, Gibson CM, Dibattiste PM, et al,. Timing of angiography and revascularization in acute coronary syndromes: An analysis of the TACTICS-TIMI-18 trial. J Interv Cardiol 2004; 17: 81-86. (Pubitemid 38648473)
11. Tricoci P, Lokhnygina Y, Berdan LG, et al,. Time to coronary angiography and outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes: Results from the synergy trial. Circulation 2007; 116: 2669-2677. (Pubitemid 350291239)
12. Montalescot G, Dabbous OH, Lim MJ, et al,. Relation of timing of cardiac catheterization to outcomes in patients with non-ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational global registry of acute coronary events. Am J Cardiol 2005; 95: 1397-1403. (Pubitemid 40824756)
13. Riezebos RK, Ronner E, Ter Bals E, et al,. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart 2009; 95: 807-812.
14. Mehta SR, Granger CB, Boden WE, et al,. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009; 360: 2165-2175.
15. Al-Mallah M, Dajani K, Hudson M, et al,. Long-term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromes. J Invasive Cardiol 2005; 17: 251-255. (Pubitemid 40632190)
16. Ronner E, Boersma E, Laarman GJ, et al,. Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: An analysis of the pursuit trial. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy. J Am Coll Cardiol 2002; 39: 1924-1929. (Pubitemid 34628272)
17. Ronner E, Boersma E, Akkerhuis KM, et al,. Patients with acute coronary syndromes without persistent st elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J 2002; 23: 239-246. (Pubitemid 36358246)
18. McCullough PA, O'Neill WW, Graham M, et al,. A time-to-treatment analysis in the medicine versus angiography in thrombolytic exclusion (mate) trial. J Interv Cardiol 2001; 14: 415-422. (Pubitemid 32846458)
19. Montalescot G, Cayla G, Collet JP, et al,. Immediate vs delayed intervention for acute coronary syndromes: A randomized clinical trial. JAMA 2009; 302: 947-954.
20. The Cochrane Collaboration Handbook for Systematic Reviews of Interventions. Available at:. Last accessed on 10 August 2007.
21. Yusuf S, Reddy S, Ounpuu S, et al,. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753. (Pubitemid 33108145)
22. Brennan JM, Petersen JL,. Early intervention: Which patients and how early? Curr Cardiol Rep 2008; 10: 303-311.
23. Boden WE,. What is the optimum role and timing of early invasive management of patients with acute coronary syndromes? Nat Clin Pract Cardiovasc Med 2006; 3: 72-73. (Pubitemid 43203372)
24. Tricoci P,. Time to coronary angiography in patients with non-ST-segment elevation acute coronary syndrome: How fast should patients go to the catheterization laboratory? Curr Opin Cardiol 2008; 23: 585-590.
25. Niemela K, Vikman S,. Early invasive therapy of non-ST-elevation acute coronary syndromes-combined with upstream antiplatelet therapy: Yes-but how early? Eur Heart J 2003; 24: 1383-1384. (Pubitemid 36961827)
26. Normand SL,. Evaluating the optimal timing of angiography: Landmark or off the mark? Circulation 2007; 116: 2656-2657.
27. Cannon CP, Harrington RA, James S, et al,. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (plato): A randomised double-blind study. Lancet 2010; 375: 283-293.